Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
56.87 GBX | -0.58% | -3.61% | +53.70% |
May. 30 | Afentra seeking further growth opportunities after "milestone" year | AN |
May. 23 | Celadon ships to US; Oxford BioDynamics-Goodbody pact | AN |
Sales 2023 | 20.76M 26.54M | Sales 2024 * | 107M 136M | Capitalization | 126M 161M |
---|---|---|---|---|---|
Net income 2023 | -2M -2.56M | Net income 2024 * | 36M 46.02M | EV / Sales 2023 | 3.92 x |
Net Debt 2023 * | 14.49M 18.52M | Net cash position 2024 * | 19.55M 24.99M | EV / Sales 2024 * | 1 x |
P/E ratio 2023 |
-39.2
x | P/E ratio 2024 * |
3.5
x | Employees | 11 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 52.73% |
1 day | -0.58% | ||
1 week | -3.61% | ||
Current month | -5.22% | ||
1 month | +12.39% | ||
3 months | +40.07% | ||
6 months | +79.12% | ||
Current year | +53.70% |
Managers | Title | Age | Since |
---|---|---|---|
Paul McDade
CEO | Chief Executive Officer | 60 | 21-03-15 |
Director of Finance/CFO | 51 | 21-05-04 | |
Ian Cloke
COO | Chief Operating Officer | 52 | 21-03-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 21-03-29 | |
Gavin Wilson
BRD | Director/Board Member | 60 | 21-03-29 |
Paul McDade
CEO | Chief Executive Officer | 60 | 21-03-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 56.87 | -0.58% | 141 984 |
24-06-05 | 57.2 | +0.35% | 500,607 |
24-06-04 | 57 | -3.72% | 1,720,918 |
24-06-03 | 59.2 | -1.33% | 810,877 |
24-05-31 | 60 | +1.69% | 1,200,511 |
Delayed Quote London S.E., June 06, 2024 at 04:19 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+53.70% | 161M | |
+3.90% | 286B | |
-3.31% | 131B | |
+62.31% | 128B | |
+12.95% | 76.53B | |
-0.53% | 69.14B | |
+0.22% | 53.06B | |
+1.98% | 45.15B | |
-12.72% | 34.21B | |
+22.00% | 33.74B |
- Stock Market
- Equities
- SEY Stock